Forbes contributors publish independent expert analyses and insights. I write about investing, markets and Berkshire Hathaway. "As for the future, Berkshire will always hold a boatload of cash and U.S ...
Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary efficacy endpoint in a Phase 2 cohort of heavily pre-treated patients with HER2-expressing, recurrent ...
Duality Biotherapeutics, Inc. operates as a clinical stage company. It focuses on the development of next generation antibody-drug conjugate therapeutics and duality immune toxin antibody conjugate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results